← All indications
Hyperglycemia
Abnormally high BLOOD GLUCOSE level.
Subtype terms (1)
More specific conditions that are subtypes of Hyperglycemia in the MeSH hierarchy.
- Glucose Intolerance
124 drugs (62 approved, 62 experimental)
Drugs by status
Approved for this indication (6)
Phase 4 trials (43)
- simvastatin
- metformin
- ringer's lactate
- insulin glulisine
- urea
- barberry
- berberine
- colesevelam
- exenatide
- dulaglutide
- ziprasidone
- insulin glargine
- glipizide
- liraglutide
- acarbose
- rosuvastatin
- potassium
- insulin human
- hydrocortisone
- icosapent ethyl
- insulin detemir
- olanzapine
- atorvastatin
- saxagliptin
- pravastatin
- risperidone
- sitagliptin
- crocus
- semaglutide
- clonidine
- +13 more
Phase 3 trials (16)
Phase 2 trials (13)
Phase 1 trials (15)
Other trials (86)
- maltodextrin
- sucrose
- beetroot juice
- beta-hydroxybutyrate
- ibuprofen
- fiber
- sevoflurane
- ginger
- l-glutamine
- glycerin
- mecasermin
- insulin degludec
- whey protein
- ketone
- l-alanine
- leucine
- nigella sativa
- nondigestible oligosaccharide
- vitamin c
- tobacco
- beta-glucans
- cow milk
- pomegranate
- pramlintide
- saccharin
- whole wheat allergenic extract
- glucagon
- apple
- autologous microbiome
- bilberry
- +56 more
Organizations
Organization Involved with Phase 4 Indications (65)
- Amylin
- Bristol-Myers Squibb
- AstraZeneca
- Merck
- Novo Nordisk
- Eli Lilly
- Sanofi
- Mylan
- Novartis
- LMC Diabetes & Endocrinology Ltd.
- Genovate Biotechnology Co., Ltd.,
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of General Medical Sciences (NIGMS)
- University of Roma La Sapienza
- University of Pittsburgh
- Medical University of Graz
- Baylor University
- Birjand University of Medical Sciences
- Chang Gung University
- Harvard University
- Emory University
- Temple University
- HealthPartners Institute
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Lianyungang Oriental Hospital
- Melbourne Health
- New York University
- Northwestern University
- Ohio State University
- +35 more
Organization Involved with Phase 3 Indications (34)
- Boehringer Ingelheim
- National Cancer Institute (NCI)
- National Institute of Neurological Disorders and Stroke (NINDS)
- Aarhus University
- Augusta University
- Katholieke Universiteit Leuven
- McMaster University
- Risk Factor Modification Centre
- Rutgers University
- Shriners Hospitals for Children
- University of Medicine and Dentistry of New Jersey
- University of Michigan
- University of Toronto
- University of Virginia
- Mayo Clinic
- Taipei Medical University
- Tel Aviv University
- University of Vienna
- PreEmptive Meds, Pvt. Ltd
- Medical University of Vienna
- Hospital Regional Alta Especialidad Bajio
- National Taiwan University
- University of Sao Paulo
- University of Texas, Galveston
- Universidad Autonoma de Barcelona
- State University of New York, Buffalo
- Humboldt University
- Canadian Institutes of Health Research (CIHR)
- Juvenile Diabetes Research Foundation
- Neurological Emergencies Treatment Trials Network
- +4 more
Organization Involved with Phase 2 Indications (26)
- Boston Therapeutics
- Danisco
- Hamad Medical Corporation
- Danish Heart Foundation
- Veterans Medical Research Foundation
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Aging (NIA)
- University of Pennsylvania
- Bastyr University
- University of London
- University of Washington
- Mahidol University
- University of Glasgow
- University of Guadalajara
- University of Oslo
- Wake Forest University
- Chinese University of Hong Kong
- HYKS-instituutti Oy
- Pennsylvania State University
- Charles Drew University
- University of Yaounde
- National Center for Advancing Translational Science (NCATS)
- The Stroke Association, United Kingdom
- Cameroon Nutritional Science Society
- Isra University
Organization Involved with Phase 1 Indications (14)
- Yabao Pharmaceutical Group
- B & Y Technologies
- German Research Foundation
- Addis Ababa University
- Duke University
- Guangzhou Medical University
- Yale University
- Vanderbilt University
- University of Indonesia
- Columbus State University
- Prism Research
- Ludwig Maximilians University
- University of Botswana
- The 12th People's Hospital of Shenzhen City
Organization Involved with Other Experimental Indications (81)
- Pfizer
- DoubleGood AB
- InQpharm Group
- Natural Immune Systems Inc
- National Center for Research Resources (NCRR)
- Flyvbjerg, Allan, DMSc
- Region Skane
- Huazhong University of Science and Technology
- University of Illinois
- Baskent University
- Case Western Reserve University
- Georgetown University
- Harokopio University
- Lund University
- McGill University
- Osaka University
- Radboud University
- Stanford University
- Tanta University
- The Royal Bournemouth Hospital
- Texas Woman's University
- University of Eastern Finland
- University of Iowa
- University of Kansas
- University of Leeds
- University of Oklahoma
- University of South Carolina
- University of Southern California
- University of Sydney
- University of Tennessee
- +51 more